| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President &CEO
1 company
Robin Howard W serves as a President &CEO at NKTR. Across recent SEC filings that breaks down to 0 buys and 97 sells. Those positions are worth an estimated $5.8M at current prices.
Historically, Robin Howard W's trades have earned a middling insider score of 58/100 across 25 rated trades. Over a 12-month horizon, 47.4% of those trades were profitable, with an average 12-month return of -8.4%.
The biggest single holding is NKTR (~$5.8M) as President &CEO. The recent filings there lean toward selling, a net 3,591,677 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2015 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 125,001 | $15.87 | $1,983,765.87 | -92.6% | |
| Nov 11, 2015 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 125,000 | $13.52 | $1,690,000.00 | -92.6% | |
| Oct 6, 2015 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 125,000 | $10.99 | $1,373,750.00 | -92.6% | |
| Sep 23, 2015 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 124,999 | $13.04 | $1,629,986.96 | -92.6% | |
| Aug 13, 2015 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 58,333 | $10.89 | $635,246.37 | -85.4% | |
| Jul 14, 2015 | NKTR Nektar Therapeutics | President &CEO | Sale+OE | 58,334 | $11.78 | $687,174.52 | -85.4% |